Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.97 USD | +1.37% | -8.33% | +137.60% |
06-18 | Lexaria Bioscience Hires Contract Research Organization For 12-week Study | MT |
06-18 | Lexaria Awards CRO Contract for 12-Week DehydraTECH GLP-1 Chronic Human Study | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+137.60% | 42.54M | |
+52.93% | 803B | |
+41.27% | 631B | |
-7.08% | 351B | |
+17.40% | 324B | |
+10.58% | 303B | |
+16.77% | 243B | |
+2.13% | 228B | |
+10.23% | 217B | |
+6.24% | 164B |
- Stock Market
- Equities
- LEXX Stock
- News Lexaria Bioscience Corp.
- Lexaria Bioscience Completes Dosing in Second Round of Semaglutide Formulations Human Pilot Study